Cyclo Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cyclo Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 22% to $1,076,405. Profit margin reached -1863%. Total operating expenses were $21,035,249.
Profit Margin
| 2014 | 1.56M | -592.68K | -37.81% |
|---|---|---|---|
| 2015 | 950.45K | -2.55M | -268.44% |
| 2016 | 1.50M | -4.22M | -281.04% |
| 2017 | 1.23M | -3.83M | -309.68% |
| 2018 | 1.01M | -4.25M | -420.68% |
| 2019 | 1.00M | -7.67M | -761.94% |
| 2020 | 903.37K | -8.92M | -987.75% |
| 2021 | 1.58M | -14.30M | -902.1% |
| 2022 | 1.37M | -15.27M | -1110.65% |
| 2023 | 1.07M | -20.05M | -1863.36% |
CYTHW Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.07M | 1.37M | 1.58M | 903.37K | 1.00M | 1.01M | 1.23M | 1.50M | 950.45K | 1.56M |
Cost of revenue | 98.45K | 138.92K | 156.08K | 66.39K | 75.49K | 105.02K | 132.91K | 198.42K | 124.42K | 272.64K |
Gross profit | 977.94K | 1.23M | 1.42M | 836.97K | 931.70K | 906.45K | 1.10M | 1.30M | 826.03K | 1.29M |
Operating exp. | ||||||||||
Research and development | 14.18M | 8.99M | 9.15M | 6.09M | 4.86M | 2.71M | 2.29M | 1.86M | 658.50K | 94.13K |
Selling and marketing | 3.90K | 13.06K | 18.33K | 5.00K | 5.88K | 5.64K | 7.84K | 7.15K | 7.56K | 10.89K |
Total operating expenses | 21.03M | 16.84M | 15.69M | 9.79M | 8.32M | 5.16M | 4.94M | 4.64M | 3.09M | 1.85M |
Operating income | -20.05M | -15.61M | -14.26M | -8.96M | -7.39M | -4.26M | -3.84M | -4.20M | -2.40M | -562.31K |
Other income (expenses), net | -7.24K | 160.72K | -18.52K | 19.80K | -141.74K | -377 | 10.26K | -853.01K | -24.62K | -30.37K |
Income before tax | -20.05M | -15.45M | -14.28M | -8.94M | -7.53M | -4.25M | -3.83M | -4.22M | -2.43M | -592.68K |
Income tax expense | 0 | -170.99K | 18.52K | -18.53K | 141.74K | 11.77K | 0 | 28.60K | 120K | 33.67K |
Net income | -20.05M | -15.27M | -14.30M | -8.92M | -7.67M | -4.25M | -3.83M | -4.22M | -2.55M | -592.68K |
Earnings per share | ||||||||||
Basic EPS | -1.23 | -1.81 | -2.25 | -5.58 | -7.09 | -5.2 | -5.32 | -6.67 | -4.54 | -1.17 |
Diluted EPS | -1.23 | -1.81 | -2.25 | -5.58 | -7.09 | -5.2 | -5.32 | -6.67 | -4.54 | -1.17 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |